117 related articles for article (PubMed ID: 22893256)
1. Poly(2-ethyl-2-oxazoline) as matrix excipient for drug formulation by hot melt extrusion and injection molding.
Claeys B; Vervaeck A; Vervaet C; Remon JP; Hoogenboom R; De Geest BG
Macromol Rapid Commun; 2012 Oct; 33(19):1701-7. PubMed ID: 22893256
[TBL] [Abstract][Full Text] [Related]
2. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
[TBL] [Abstract][Full Text] [Related]
3. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
4. Poly(2-alkyl-2-oxazoline)s: A polymer platform to sustain the release from tablets with a high drug loading.
Samaro A; Vergaelen M; Purino M; Tigrine A; de la Rosa VR; Goudarzi NM; Boone MN; Vanhoorne V; Hoogenboom R; Vervaet C
Mater Today Bio; 2022 Dec; 16():100414. PubMed ID: 36133793
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
[TBL] [Abstract][Full Text] [Related]
6. Injection molding as a one-step process for the direct production of pharmaceutical dosage forms from primary powders.
Eggenreich K; Windhab S; Schrank S; Treffer D; Juster H; Steinbichler G; Laske S; Koscher G; Roblegg E; Khinast JG
Int J Pharm; 2016 May; 505(1-2):341-51. PubMed ID: 27012981
[TBL] [Abstract][Full Text] [Related]
7. Creating Drug Solubilization Compartments via Phase Separation in Multicomponent Buccal Patches Prepared by Direct Hot Melt Extrusion-Injection Molding.
Alhijjaj M; Bouman J; Wellner N; Belton P; Qi S
Mol Pharm; 2015 Dec; 12(12):4349-62. PubMed ID: 26551593
[TBL] [Abstract][Full Text] [Related]
8. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
Patil H; Feng X; Ye X; Majumdar S; Repka MA
AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion.
Ranzani LS; Font J; Galimany F; Santanach A; Gomez-Gomar AM; Casadevall G; Gryczke A
Drug Dev Ind Pharm; 2011 Jun; 37(6):694-701. PubMed ID: 21226628
[TBL] [Abstract][Full Text] [Related]
11. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
[TBL] [Abstract][Full Text] [Related]
12. The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.
Bouman J; Belton P; Venema P; van der Linden E; de Vries R; Qi S
Pharm Res; 2015 Aug; 32(8):2775-86. PubMed ID: 25777612
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion.
Deng W; Majumdar S; Singh A; Shah S; Mohammed NN; Jo S; Pinto E; Tewari D; Durig T; Repka MA
Drug Dev Ind Pharm; 2013 Feb; 39(2):290-8. PubMed ID: 22524504
[TBL] [Abstract][Full Text] [Related]
14. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices.
Dierickx L; Saerens L; Almeida A; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Aug; 81(3):683-9. PubMed ID: 22504402
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
16. Development of Maltodextrin-Based Immediate-Release Tablets Using an Integrated Twin-Screw Hot-Melt Extrusion and Injection-Molding Continuous Manufacturing Process.
Puri V; Brancazio D; Desai PM; Jensen KD; Chun JH; Myerson AS; Trout BL
J Pharm Sci; 2017 Nov; 106(11):3328-3336. PubMed ID: 28684263
[TBL] [Abstract][Full Text] [Related]
17. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of poly(2-ethyl-2-oxazoline) containing copolymer networks of varied composition as sustained metoprolol tartrate delivery systems.
Kostova B; Ivanova S; Balashev K; Rachev D; Christova D
AAPS PharmSciTech; 2014 Aug; 15(4):939-46. PubMed ID: 24789663
[TBL] [Abstract][Full Text] [Related]
19. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
[TBL] [Abstract][Full Text] [Related]
20. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
